InfuSystem Holdings, Inc Return Tang Equity
Return on tangible equity is the profit a company earns on the physical and financial capital its shareholders own, leaving out goodwill and other intangible assets, shown as a percentage. It is net income divided by tangible equity, which is shareholder equity minus goodwill and intangibles; the table shows both amounts. Because acquired goodwill is removed, it runs higher than ROE for companies that grew by acquisition, and it has no meaning when goodwill exceeds equity. Goodwill and intangibles are taken at the latest reported date on or before each equity date. Quarterly points divide the trailing four quarters of net income by the balance at that quarter end; annual points divide the filed fiscal-year net income by the fiscal-year-end balance.
- InfuSystem Holdings, Inc return tang equity for the quarter ending 2026-06-30 was 16.77%, a 50.98% increase year-over-year.
- InfuSystem Holdings, Inc return tang equity for the quarter ending 2026-03-31 was 15.70%, a 132.47% increase year-over-year.
- InfuSystem Holdings, Inc return tang equity for the quarter ending 2025-12-31 was 13.65%, a 185.95% increase year-over-year.
- InfuSystem Holdings, Inc return tang equity for the quarter ending 2025-09-30 was 11.83%, a 275.55% increase year-over-year.
- InfuSystem Holdings, Inc return tang equity for fiscal 2025 was 12.84%, a 183.71% increase from fiscal 2024.
- InfuSystem Holdings, Inc return tang equity for fiscal 2024 was 4.53%, a 141.80% increase from fiscal 2023.
- InfuSystem Holdings, Inc return tang equity for fiscal 2023 was 1.87%, a 4297.45% increase from fiscal 2022.
- InfuSystem Holdings, Inc return tang equity for fiscal 2022 was 0.04%, a 98.72% decline from fiscal 2021.
- Available history
- 2009-12-31 to 2026-06-30
- Data captured
Historical Return Tang Equity
Annual Return Tang Equity
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| Profound Medical Corp. (PROF) | $0.206B | -7.37 |